Response to interferon α therapy is influenced by the iron content of the liver
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 20 (3), 410-415
- https://doi.org/10.1016/s0168-8278(94)80017-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Use of α-interferon in the treatment of chronic delta hepatitisJournal of Hepatology, 1991
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitisDigestive Diseases and Sciences, 1991
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisGastroenterology, 1991
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis B with Interferon: Experience in Western CountriesSeminars in Liver Disease, 1989
- Treatment of Chronic Hepatitis B with Interferon: Experience in Asian PatientsSeminars in Liver Disease, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Low molecular weight intracellular iron transport compoundsBlood, 1977